Last 25 quarters of trend data · Healthcare · Biotechnology
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -2.75 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 113.69 | 140.08 | 162.35 | 120.59 | 133.49 | 152.24 | 64.95 | 82.86 | 39.91 | 59.90 | 152.79 | 177.85 | 263.63 | 308.90 | 243.00 | — | — | — | — | — | — |
| — | -8.0% | +150.0% | +45.5% | +234.5% | +154.2% | -57.5% | -53.4% | -84.9% | -80.6% | -37.1% | — | — | — | — | — | — | — | — | — | — | |
| P/B Ratio | 1.26 | 1.07 | 0.83 | 0.99 | 1.25 | 1.63 | 0.89 | 1.83 | 0.60 | 0.64 | 1.10 | 1.05 | 0.81 | 0.80 | 0.73 | 0.71 | 0.99 | 0.78 | 1.47 | 2.27 | 2.30 |
| — | -34.3% | -5.8% | -46.1% | +110.0% | +154.9% | -19.5% | +75.1% | -25.9% | -20.5% | +51.1% | +46.8% | -18.7% | +3.0% | -50.4% | -68.5% | -57.0% | +174.1% | -42.6% | +49.8% | — | |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 47.3% | 50.0% | 28.7% | 27.1% | 35.1% | 59.4% | 57.7% | 51.2% | 46.6% | 56.9% | 58.9% | 44.5% | 48.4% | 38.0% | 48.8% | — | — | — | — | — | — |
| — | -15.8% | -50.3% | -47.1% | -24.6% | +4.4% | -1.9% | +15.0% | -3.7% | +49.6% | +20.6% | — | — | — | — | — | — | — | — | — | — | |
| Operating Margin | -3996.7% | -7450.3% | -9322.9% | -4677.2% | -4419.6% | -4527.6% | -2982.4% | -2573.6% | -3569.0% | -4252.6% | -5111.6% | -6970.8% | -12186.1% | -13118.0% | -11504.3% | — | — | — | — | — | — |
| — | -64.6% | -212.6% | -81.7% | -23.8% | -6.5% | +41.7% | +63.1% | +70.7% | +67.6% | +55.6% | — | — | — | — | — | — | — | — | — | — | |
| Net Margin | -4160.1% | -6841.3% | -8399.6% | -3904.9% | -6467.9% | -4879.2% | -2279.0% | -2778.6% | -3216.4% | -3713.7% | -4261.3% | -5512.0% | -11088.8% | -12474.6% | -9295.7% | — | — | — | — | — | — |
| — | -40.2% | -268.6% | -40.5% | -101.1% | -31.4% | +46.5% | +49.6% | +71.0% | +70.2% | +54.2% | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -46.5% | -12.4% | -10.3% | -7.7% | -15.7% | -12.3% | -8.3% | -15.6% | -11.4% | -9.5% | -7.4% | -7.8% | -8.1% | -7.8% | -6.8% | -8.9% | -7.9% | -7.6% | -7.7% | -6.1% | -3.6% |
| — | -0.2% | -24.0% | +50.3% | -37.2% | -29.9% | -12.0% | -98.8% | -40.1% | -21.3% | -9.5% | +11.9% | -2.8% | -3.1% | +11.6% | -46.6% | -118.4% | +43.8% | +79.9% | +52.9% | +68.7% | |
| ROA | -41.1% | -11.6% | -9.4% | -7.0% | -13.9% | -11.0% | -7.4% | -13.7% | -10.3% | -8.7% | -6.8% | -7.2% | -7.5% | -7.2% | -6.2% | -8.2% | -7.4% | -7.1% | -7.2% | -5.8% | -3.5% |
| — | -5.4% | -27.7% | +49.1% | -35.2% | -26.4% | -8.9% | -91.2% | -36.8% | -19.8% | -8.7% | +12.6% | -1.9% | -2.7% | +13.1% | -40.9% | -111.0% | +44.7% | +77.5% | +52.2% | +52.5% | |
| ROIC | -38.2% | -11.7% | -9.7% | -7.7% | -8.7% | -9.3% | -9.4% | -12.7% | -11.4% | -9.9% | -9.5% | -11.4% | -8.9% | -7.8% | -7.7% | -9.4% | -6.1% | -5.9% | -4.7% | -4.7% | -9.1% |
| — | -26.0% | -3.5% | +39.7% | +23.4% | +5.7% | +1.3% | -11.7% | -27.9% | -26.5% | -22.9% | -21.0% | -45.2% | -32.9% | -66.0% | -99.3% | +32.7% | — | +99.5% | +63.0% | -27.7% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.05 | 0.05 | 0.06 | 0.07 | 0.06 | 0.06 | 0.06 | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 | 0.04 | 0.04 | 0.02 | — |
| — | -64.2% | -62.1% | -68.5% | -70.1% | -13.8% | -14.5% | +6.7% | +24.1% | +13.8% | +15.8% | +15.8% | +20.2% | +23.5% | +33.1% | +187.2% | — | — | -45.9% | -65.1% | — | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 7.64 | 9.97 | 12.60 | 7.64 | 10.75 | 9.43 | 19.24 | 11.99 | 13.42 | 20.57 | 30.65 | 22.94 | 25.88 | 30.10 | 32.69 | 22.81 | 29.97 | 35.44 | 31.31 | 41.39 | 70.21 |
| — | +5.7% | -34.5% | -36.3% | -19.9% | -54.2% | -37.2% | -47.7% | -48.2% | -31.6% | -6.2% | +0.6% | -13.7% | -15.1% | +4.4% | -44.9% | -57.3% | -46.8% | +479.7% | +201.1% | +363.1% | |
| Quick Ratio | 7.50 | 9.97 | 12.40 | 7.50 | 10.59 | 9.27 | 18.89 | 11.76 | 13.15 | 20.13 | 30.03 | 22.60 | 25.66 | 29.90 | 32.52 | 22.81 | 29.97 | 35.44 | 31.31 | 41.39 | 70.21 |
| — | +7.6% | -34.4% | -36.3% | -19.5% | -54.0% | -37.1% | -47.9% | -48.8% | -32.7% | -7.6% | -0.9% | -14.4% | -15.6% | +3.9% | -44.9% | -57.3% | -46.8% | +479.7% | +201.1% | +363.1% | |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 25 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying QSI stock.
Quantum-Si incorporated's current P/E is -2.7x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Quantum-Si incorporated's current operating margin is -3996.7%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Quantum-Si incorporated's business trajectory between earnings reports.